275 related articles for article (PubMed ID: 31492621)
21. Retention of antimony in hair during leishmaniasis treatment.
Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J
Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007
[No Abstract] [Full Text] [Related]
22. [Open therapeutic study with aminosidine sulfate in mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis].
Romero GA; Lessa HA; Macêdo VO; Carvalho EM; Barral A; Magalhães AV; Orge MG; Abreu MV; Marsden PD
Rev Soc Bras Med Trop; 1996; 29(6):557-65. PubMed ID: 9011880
[TBL] [Abstract][Full Text] [Related]
23. Mucocutaneous leishmaniasis masquerading as Wegener granulomatosis.
Brahn E; Pegues DA; Yao Q; Craft N
J Clin Rheumatol; 2010 Apr; 16(3):125-8. PubMed ID: 20375822
[TBL] [Abstract][Full Text] [Related]
24. Comparative proteomics study on meglumine antimoniate sensitive and resistant Leishmania tropica isolated from Iranian anthroponotic cutaneous leishmaniasis patients.
Hajjaran H; Azarian B; Mohebali M; Hadighi R; Assareh A; Vaziri B
East Mediterr Health J; 2012 Feb; 18(2):165-71. PubMed ID: 22571094
[TBL] [Abstract][Full Text] [Related]
25. Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol.
Antezana G; Zeballos R; Mendoza C; Lyevre P; Valda L; Cardenas F; Noriega I; Ugarte H; Dedet JP
Trans R Soc Trop Med Hyg; 1992; 86(1):31-3. PubMed ID: 1566297
[TBL] [Abstract][Full Text] [Related]
26. Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials.
Veiga JP; Wolff ER; Sampaio RN; Marsden PD
Lancet; 1983 Sep; 2(8349):569. PubMed ID: 6136717
[No Abstract] [Full Text] [Related]
27. [Mucosal leishmaniasis by contiguity with a skin lesion: another case report from Tunisia].
El Fékih N; Sliti N; Kharfi M; Trabelsi S; Khaled S; Fazaa B; Kamoun MR
Med Trop (Mars); 2008 Dec; 68(6):634-6. PubMed ID: 19639835
[TBL] [Abstract][Full Text] [Related]
28. High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis.
Marsden PD; Sampaio RN; Carvalho EM; Veiga JP; Costa JL; Llanos-Cuentas EA
Am J Trop Med Hyg; 1985 Jul; 34(4):710-3. PubMed ID: 2992304
[TBL] [Abstract][Full Text] [Related]
29. Treatment of imported New World cutaneous leishmaniasis in Germany.
Harms G; Scherbaum H; Reiter-Owona I; Stich A; Richter J
Int J Dermatol; 2011 Nov; 50(11):1336-1342. PubMed ID: 22004484
[TBL] [Abstract][Full Text] [Related]
30. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
[TBL] [Abstract][Full Text] [Related]
31. [Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis].
Garcia Bustos MF; Barrio A; Parodi C; Beckar J; Moreno S; Basombrio MA
Medicina (B Aires); 2014; 74(5):371-7. PubMed ID: 25347898
[TBL] [Abstract][Full Text] [Related]
32. Case Report: Unusual Presentation of Pharyngeal Mucosal Leishmaniasis due to
Figueiredo LP; Almeida LDC; Magalhães A; Arruda S; Lessa MM; Carvalho EM
Am J Trop Med Hyg; 2020 Oct; 103(4):1493-1495. PubMed ID: 32748768
[TBL] [Abstract][Full Text] [Related]
33. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
Motta AC; Arruda D; Souza CS; Foss NT
Int J Dermatol; 2003 Sep; 42(9):703-6. PubMed ID: 12956682
[TBL] [Abstract][Full Text] [Related]
34. [A fatal case of mucocutaneous leishmaniasis after pentavalent antimonial use].
Oliveira MC; Amorim RF; Freitas Rde A; Costa Ade L
Rev Soc Bras Med Trop; 2005; 38(3):258-60. PubMed ID: 15895180
[TBL] [Abstract][Full Text] [Related]
35. [Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters].
Rezzano S; Armas JA; Moreno G; Scorza JV
Acta Cient Venez; 1984; 35(5-6):394-403. PubMed ID: 6537698
[No Abstract] [Full Text] [Related]
36. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
Grogl M; Thomason TN; Franke ED
Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070
[TBL] [Abstract][Full Text] [Related]
37. [Renal function in patients with mucocutaneous leishmaniasis treated with pentavalent antimony compounds].
Veiga JP; Rosa TT; Kimachi T; Wolff ER; Sampaio RN; Gagliardi AR; Junqueira Júnior LF; Costa JM; Marsden PD
Rev Inst Med Trop Sao Paulo; 1985; 27(6):298-302. PubMed ID: 3014634
[No Abstract] [Full Text] [Related]
38. Combined antimonial allopurinol therapy in mucosal leishmaniasis.
Sampaio RN; Marchán EM; Vexenat A; Tristão RJ; Marsden PD
Mem Inst Oswaldo Cruz; 1990; 85(3):373-4. PubMed ID: 2134714
[No Abstract] [Full Text] [Related]
39. Berberine derivatives as antileishmanial drugs.
Vennerstrom JL; Lovelace JK; Waits VB; Hanson WL; Klayman DL
Antimicrob Agents Chemother; 1990 May; 34(5):918-21. PubMed ID: 2360830
[TBL] [Abstract][Full Text] [Related]
40. [Miltefosine or meglumine antimoniate in leishmaniasis].
Joob B; Wiwanitkit V
Medicina (B Aires); 2015; 75(2):130-1. PubMed ID: 25919881
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
